Molecular Species of Phosphatidylinositol-Cycle Intermediates in the Endoplasmic Reticulum and Plasma Membrane

Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and PI and their acyl chain compositions in these two subcellular membranes using mass spectrometry. We assessed the role of PI cycling in determi...

Full description

Saved in:
Bibliographic Details
Published in:Biochemistry (Easton) Vol. 49; no. 2; pp. 312 - 317
Main Authors: Shulga, Yulia V, Myers, David S, Ivanova, Pavlina T, Milne, Stephen B, Brown, H. Alex, Topham, Matthew K, Epand, Richard M
Format: Journal Article
Language:English
Published: United States American Chemical Society 19-01-2010
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and PI and their acyl chain compositions in these two subcellular membranes using mass spectrometry. We assessed the role of PI cycling in determining the molecular species and quantity of these lipids by comparing the compositions of the two membranes isolated from embryonic fibroblasts obtained from diacylglycerol kinase ε (DGKε) knockout (KO) and wild-type (WT) mice. In the KO cells, the conversion of arachidonoyl-rich DAG to PA is blocked by the absence of DGKε, resulting in a reduction in the rate of PI cycling. The acyl chain composition is very similar for PI and PA in the endoplasmic reticulum (ER) versus plasma membrane (PM) and for WT versus KO. However, the acyl chain profile for PI is very different from that for PA. This indicates that DGKε is not facilitating the direct transfer of a specific species of PA between the PM and the ER. Approximately 20% of the PA in the ER membrane has one short acyl chain of 14 or fewer carbons. These species of PA are not converted into PI but may play a role in stabilizing regions of high positive curvature in the ER. There are also PI species in both the ER and PM for which there is no detectable PA precursor, indicating that these species of PI are unlikely to arise via the PI cycle. We find that in the PM of KO cells the levels of PI and of PA are decreased ∼3-fold in comparison with those in either the PM of WT cells or the ER of KO cells. The PI cycle is slowed in the KO cells; hence, the lipid intermediates of the PI cycle can no longer be interconverted and are depleted from the PI cycle by conversion to other species. There is less of an effect of the depletion in the ER where de novo synthesis of PA occurs in comparison with the PM.
AbstractList Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and PI and their acyl chain compositions in these two subcellular membranes using mass spectrometry. We assessed the role of PI cycling in determining the molecular species and quantity of these lipids by comparing the compositions of the two membranes isolated from embryonic fibroblasts obtained from diacylglycerol kinase ε (DGKε) knockout (KO) and wild-type (WT) mice. In the KO cells, the conversion of arachidonoyl-rich DAG to PA is blocked by the absence of DGKε, resulting in a reduction in the rate of PI cycling. The acyl chain composition is very similar for PI and PA in the endoplasmic reticulum (ER) versus plasma membrane (PM) and for WT versus KO. However, the acyl chain profile for PI is very different from that for PA. This indicates that DGKε is not facilitating the direct transfer of a specific species of PA between the PM and the ER. Approximately 20% of the PA in the ER membrane has one short acyl chain of 14 or fewer carbons. These species of PA are not converted into PI but may play a role in stabilizing regions of high positive curvature in the ER. There are also PI species in both the ER and PM for which there is no detectable PA precursor, indicating that these species of PI are unlikely to arise via the PI cycle. We find that in the PM of KO cells the levels of PI and of PA are decreased ∼3-fold in comparison with those in either the PM of WT cells or the ER of KO cells. The PI cycle is slowed in the KO cells; hence, the lipid intermediates of the PI cycle can no longer be interconverted and are depleted from the PI cycle by conversion to other species. There is less of an effect of the depletion in the ER where de novo synthesis of PA occurs in comparison with the PM.
Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and PI and their acyl chain compositions in these two subcellular membranes using mass spectrometry. We assessed the role of PI cycling in determining the molecular species and quantity of these lipids by comparing the compositions of the two membranes isolated from embryonic fibroblasts obtained from diacylglycerol kinase epsilon (DGKepsilon) knockout (KO) and wild-type (WT) mice. In the KO cells, the conversion of arachidonoyl-rich DAG to PA is blocked by the absence of DGKepsilon, resulting in a reduction in the rate of PI cycling. The acyl chain composition is very similar for PI and PA in the endoplasmic reticulum (ER) versus plasma membrane (PM) and for WT versus KO. However, the acyl chain profile for PI is very different from that for PA. This indicates that DGKepsilon is not facilitating the direct transfer of a specific species of PA between the PM and the ER. Approximately 20% of the PA in the ER membrane has one short acyl chain of 14 or fewer carbons. These species of PA are not converted into PI but may play a role in stabilizing regions of high positive curvature in the ER. There are also PI species in both the ER and PM for which there is no detectable PA precursor, indicating that these species of PI are unlikely to arise via the PI cycle. We find that in the PM of KO cells the levels of PI and of PA are decreased approximately 3-fold in comparison with those in either the PM of WT cells or the ER of KO cells. The PI cycle is slowed in the KO cells; hence, the lipid intermediates of the PI cycle can no longer be interconverted and are depleted from the PI cycle by conversion to other species. There is less of an effect of the depletion in the ER where de novo synthesis of PA occurs in comparison with the PM.
Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and PI and their acyl chain compositions in these two subcellular membranes using mass spectrometry. We assessed the role of PI cycling in determining the molecular species and quantity of these lipids by comparing the compositions of the two membranes isolated from embryonic fibroblasts obtained from diacylglycerol kinase epsilon (DGKε) knock out (KO) and wild type (WT) mice. In the KO cells the conversion of arachidonoyl-rich DAG to PA is blocked by the absence of DGKε, resulting in reducing the rate of PI-cycling. The acyl chain composition is very similar for PI or PA in the endoplasmic reticulum (ER) vs. plasma membrane (PM) and for WT vs. KO. However, the acyl chain profile for PI is very different from that for PA. This indicates that DGKε is not facilitating the direct transfer of a specific species of PA between the PM and the ER. About 20% of the PA in the ER membrane has one short acyl chain of 14 carbons or less. These species of PA are not converted into PI but may play a role in stabilizing regions of high positive curvature in the ER. There are also PI species in both the ER and PM for which there is no detectable PA precursor, indicating that these species of PI are unlikely to arise via the PI-cycle. We find that in the PM of KO cells the levels of PI and of PA are decreased about three-fold in comparison with either the PM of WT cells or in comparison with the ER of KO cells. The PI-cycle is slowed in the KO cells, hence the lipid intermediates of the PI-cycle can no longer be interconverted and are depleted from the PI-cycle by conversion to other species. There is less of an effect of the depletion in the ER where de novo synthesis of PA occurs in comparison with the PM.
Author Topham, Matthew K
Shulga, Yulia V
Milne, Stephen B
Brown, H. Alex
Myers, David S
Ivanova, Pavlina T
Epand, Richard M
AuthorAffiliation Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
AuthorAffiliation_xml – name: Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232
– name: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112
– name: Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
Author_xml – sequence: 1
  givenname: Yulia V
  surname: Shulga
  fullname: Shulga, Yulia V
– sequence: 2
  givenname: David S
  surname: Myers
  fullname: Myers, David S
– sequence: 3
  givenname: Pavlina T
  surname: Ivanova
  fullname: Ivanova, Pavlina T
– sequence: 4
  givenname: Stephen B
  surname: Milne
  fullname: Milne, Stephen B
– sequence: 5
  givenname: H. Alex
  surname: Brown
  fullname: Brown, H. Alex
  email: epand@mcmaster.ca, alex.brown@vanderbilt.edu
– sequence: 6
  givenname: Matthew K
  surname: Topham
  fullname: Topham, Matthew K
– sequence: 7
  givenname: Richard M
  surname: Epand
  fullname: Epand, Richard M
  email: epand@mcmaster.ca, alex.brown@vanderbilt.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20000336$$D View this record in MEDLINE/PubMed
BookMark eNptkU1rFTEUhoNU7G114R-QbES6GE0yk0lmI8il1UKLxY91yGROvCmZZEwywv33ptx6UXCVr4cn55z3DJ2EGAChl5S8pYTRd6MbCOWcwhO0oZyRphsGfoI2hJC-YUNPTtFZzvf12BHRPUOnrG5J2_YbFG6jB7N6nfDXBYyDjKPFd7uYl50ubtp7F2J2Jfpmuzce8HUokGaYnC6VdQGXHeDLMMXF6zw7g79AcVW4zliHCd893Gp8C_OYdIDn6KnVPsOLx_Ucfb-6_Lb91Nx8_ni9_XDT6E6Q0ti2l5wBp0JaKexIOB9GsJwQ2lpJiaFMSuBMwyishHbigltKuwmk7BkZ23P0_uBd1rEWayCUpL1akpt12quonfr3Jbid-hF_KSYJF72ogjePghR_rpCLml024H1tIq5ZibZjLROUV_LiQJoUc05gj79Qoh7iUcd4Kvvq77KO5J88KvD6AGiT1X1cU6hT-o_oN_ZImoY
CitedBy_id crossref_primary_10_1021_bi501250m
crossref_primary_10_1016_j_bbrc_2011_12_037
crossref_primary_10_1021_cr1004106
crossref_primary_10_1021_cr200296t
crossref_primary_10_1016_j_bbamem_2013_10_003
crossref_primary_10_1007_s00232_016_9909_y
crossref_primary_10_1016_j_bbalip_2012_10_004
crossref_primary_10_1186_s12964_021_00715_0
crossref_primary_10_1111_cmi_12101
crossref_primary_10_1016_j_exer_2014_06_007
crossref_primary_10_1016_j_plipres_2013_10_001
crossref_primary_10_1016_j_bpc_2021_106587
crossref_primary_10_1039_C8MO00060C
crossref_primary_10_1172_jci_insight_146959
crossref_primary_10_1016_j_bbalip_2019_05_015
crossref_primary_10_1016_j_bpc_2020_106431
crossref_primary_10_1016_j_febslet_2011_11_016
crossref_primary_10_1038_nrneph_2014_250
crossref_primary_10_1016_j_chemphyslip_2015_06_003
crossref_primary_10_1371_journal_pone_0058425
crossref_primary_10_1017_S0007114518000946
Cites_doi 10.1080/15216540600871142
10.1021/bi800492c
10.1038/sj.embor.7400919
10.1016/j.jmb.2008.08.076
10.1194/jlr.R800049-JLR200
10.1016/j.tibs.2006.11.004
10.1016/S0955-0674(00)00241-6
10.1093/emboj/19.20.5440
10.1038/emboj.2008.169
10.1016/B0-12-226770-2/05541-1
10.1042/BJ20071040
10.1073/pnas.081536298
10.1074/jbc.M109.050617
10.2307/1412159
10.1016/j.bbalip.2009.02.010
10.1007/s002320010069
10.1016/S0076-6879(07)32002-8
10.1016/j.bbalip.2006.03.016
10.1091/mbc.e04-12-1124
10.1038/ncb0604-487
10.1016/j.bbagen.2009.01.010
10.2174/138945008785132394
10.1002/jcb.21027
10.1016/j.tips.2003.09.003
10.1194/jlr.R800035-JLR200
ContentType Journal Article
Copyright Copyright © 2009 American Chemical Society
Copyright_xml – notice: Copyright © 2009 American Chemical Society
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1021/bi901551e
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1520-4995
EndPage 317
ExternalDocumentID 10_1021_bi901551e
20000336
b425766261
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation This work was supported in part by a grant from the Natural Sciences and Engineering Research Council of Canada (Grant 9848 to R.M.E.) and by National Institutes of Health Grants R01-CA95463 (to M.K.T.) and U54 GM069338 (to H.A.B.).
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: U54 GM069338
– fundername: NCI NIH HHS
  grantid: R01 CA095463
– fundername: NIGMS NIH HHS
  grantid: U54 GM069338-059006
– fundername: NCI NIH HHS
  grantid: R01 CA095463-07
– fundername: NCI NIH HHS
  grantid: R01-CA95463
GroupedDBID -
.K2
02
23N
3O-
4.4
53G
55
55A
5GY
5RE
5VS
7~N
85S
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ABUCX
ABUFD
ACGFS
ACJ
ACNCT
ACS
ADBIT
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
D0L
DU5
DZ
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
K2
KM
L7B
LG6
P2P
ROL
TN5
UI2
VF5
VG9
VQA
W1F
WH7
X
X7M
YZZ
ZA5
---
-DZ
-~X
.55
ABJNI
ABQRX
ADHLV
AGXLV
AHGAQ
CGR
CUPRZ
CUY
CVF
ECM
EIF
GGK
NPM
XSW
ZCA
~02
~KM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-a470t-f36852e5178f87fb0559bef50013f810c1288e52aeb7f8e3d575f114de88620b3
IEDL.DBID ACS
ISSN 0006-2960
IngestDate Tue Sep 17 21:18:17 EDT 2024
Fri Aug 16 07:58:37 EDT 2024
Fri Aug 23 01:45:00 EDT 2024
Sat Nov 02 12:26:23 EDT 2024
Sun Dec 06 13:24:35 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a470t-f36852e5178f87fb0559bef50013f810c1288e52aeb7f8e3d575f114de88620b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc2805767?pdf=render
PMID 20000336
PQID 734232715
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2805767
proquest_miscellaneous_734232715
crossref_primary_10_1021_bi901551e
pubmed_primary_20000336
acs_journals_10_1021_bi901551e
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
PublicationCentury 2000
PublicationDate 2010-01-19
PublicationDateYYYYMMDD 2010-01-19
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01-19
  day: 19
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biochemistry (Easton)
PublicationTitleAlternate Biochemistry
PublicationYear 2010
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References Ivanova P. T. (ref18/cit18) 2007; 432
Cockcroft S. (ref1/cit1) 2001; 180
Ring A. (ref16/cit16) 2006; 1761
Decaffmeyer M. (ref13/cit13) 2008; 383
Lung M. (ref14/cit14) 2009; 284
Garner J. A. (ref17/cit17) 2000
Sakane F. (ref10/cit10) 2008; 9
Krauss M. (ref15/cit15) 2007; 8
De Matteis M. A. (ref24/cit24) 2004; 6
Yang C. (ref6/cit6) 2003; 24
Spearman C. (ref19/cit19) 1904; 15
Cazzolli R. (ref3/cit3) 2006; 58
Martin T. F. (ref25/cit25) 2001; 13
Divecha N. (ref21/cit21) 2000; 19
Fagone P. (ref22/cit22) 2009; 50
Huang P. (ref4/cit4) 2005; 16
Jarquin-Pardo M. (ref20/cit20) 2007; 100
Shindou H. (ref23/cit23) 2009; 50
Vicinanza M. (ref2/cit2) 2008; 27
Milne S. B. (ref12/cit12) 2008; 47
Merida I. (ref7/cit7) 2008; 409
Cai J. (ref9/cit9) 2009; 1791
Carrasco S. (ref5/cit5) 2007; 32
Topham M. K. (ref8/cit8) 2009; 1790
Rodriguez de Turco E. B. (ref11/cit11) 2001; 98
References_xml – volume: 58
  start-page: 457
  year: 2006
  ident: ref3/cit3
  publication-title: IUBMB Life
  doi: 10.1080/15216540600871142
  contributor:
    fullname: Cazzolli R.
– volume: 47
  start-page: 9372
  year: 2008
  ident: ref12/cit12
  publication-title: Biochemistry
  doi: 10.1021/bi800492c
  contributor:
    fullname: Milne S. B.
– volume: 8
  start-page: 241
  year: 2007
  ident: ref15/cit15
  publication-title: EMBO Rep.
  doi: 10.1038/sj.embor.7400919
  contributor:
    fullname: Krauss M.
– volume: 383
  start-page: 797
  year: 2008
  ident: ref13/cit13
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2008.08.076
  contributor:
    fullname: Decaffmeyer M.
– volume: 50
  start-page: S311
  year: 2009
  ident: ref22/cit22
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R800049-JLR200
  contributor:
    fullname: Fagone P.
– volume: 32
  start-page: 27
  year: 2007
  ident: ref5/cit5
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2006.11.004
  contributor:
    fullname: Carrasco S.
– volume: 13
  start-page: 493
  year: 2001
  ident: ref25/cit25
  publication-title: Curr. Opin. Cell Biol
  doi: 10.1016/S0955-0674(00)00241-6
  contributor:
    fullname: Martin T. F.
– volume: 19
  start-page: 5440
  year: 2000
  ident: ref21/cit21
  publication-title: EMBO J.
  doi: 10.1093/emboj/19.20.5440
  contributor:
    fullname: Divecha N.
– volume: 27
  start-page: 2457
  year: 2008
  ident: ref2/cit2
  publication-title: EMBO J.
  doi: 10.1038/emboj.2008.169
  contributor:
    fullname: Vicinanza M.
– start-page: 3586
  volume-title: Encyclopedia of Separation Science
  year: 2000
  ident: ref17/cit17
  doi: 10.1016/B0-12-226770-2/05541-1
  contributor:
    fullname: Garner J. A.
– volume: 409
  start-page: 1
  year: 2008
  ident: ref7/cit7
  publication-title: Biochem. J.
  doi: 10.1042/BJ20071040
  contributor:
    fullname: Merida I.
– volume: 98
  start-page: 4740
  year: 2001
  ident: ref11/cit11
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.081536298
  contributor:
    fullname: Rodriguez de Turco E. B.
– volume: 284
  start-page: 31062
  year: 2009
  ident: ref14/cit14
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.050617
  contributor:
    fullname: Lung M.
– volume: 15
  start-page: 72
  year: 1904
  ident: ref19/cit19
  publication-title: Am. J. Psychol.
  doi: 10.2307/1412159
  contributor:
    fullname: Spearman C.
– volume: 1791
  start-page: 942
  year: 2009
  ident: ref9/cit9
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2009.02.010
  contributor:
    fullname: Cai J.
– volume: 180
  start-page: 187
  year: 2001
  ident: ref1/cit1
  publication-title: J. Membr. Biol.
  doi: 10.1007/s002320010069
  contributor:
    fullname: Cockcroft S.
– volume: 432
  start-page: 21
  year: 2007
  ident: ref18/cit18
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(07)32002-8
  contributor:
    fullname: Ivanova P. T.
– volume: 1761
  start-page: 416
  year: 2006
  ident: ref16/cit16
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2006.03.016
  contributor:
    fullname: Ring A.
– volume: 16
  start-page: 2614
  year: 2005
  ident: ref4/cit4
  publication-title: Mol. Biol. Cell
  doi: 10.1091/mbc.e04-12-1124
  contributor:
    fullname: Huang P.
– volume: 6
  start-page: 487
  year: 2004
  ident: ref24/cit24
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb0604-487
  contributor:
    fullname: De Matteis M. A.
– volume: 1790
  start-page: 416
  year: 2009
  ident: ref8/cit8
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2009.01.010
  contributor:
    fullname: Topham M. K.
– volume: 9
  start-page: 626
  year: 2008
  ident: ref10/cit10
  publication-title: Curr. Drug Targets
  doi: 10.2174/138945008785132394
  contributor:
    fullname: Sakane F.
– volume: 100
  start-page: 112
  year: 2007
  ident: ref20/cit20
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.21027
  contributor:
    fullname: Jarquin-Pardo M.
– volume: 24
  start-page: 602
  year: 2003
  ident: ref6/cit6
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2003.09.003
  contributor:
    fullname: Yang C.
– volume: 50
  start-page: S46
  year: 2009
  ident: ref23/cit23
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R800035-JLR200
  contributor:
    fullname: Shindou H.
SSID ssj0004074
Score 2.1364136
Snippet Phosphatidylinositol (PI) turnover is a process requiring both the plasma and ER membranes. We have determined the distribution of phosphatidic acid (PA) and...
SourceID pubmedcentral
proquest
crossref
pubmed
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 312
SubjectTerms Animals
Cell Fractionation - methods
Cell Membrane - metabolism
Cell Membrane - ultrastructure
Diacylglycerol Kinase - deficiency
Diacylglycerol Kinase - genetics
Endoplasmic Reticulum - metabolism
Endoplasmic Reticulum - ultrastructure
Glycerophospholipids - metabolism
Kinetics
Mice
Mice, Knockout
Models, Molecular
Phosphatidylinositols - metabolism
Title Molecular Species of Phosphatidylinositol-Cycle Intermediates in the Endoplasmic Reticulum and Plasma Membrane
URI http://dx.doi.org/10.1021/bi901551e
https://www.ncbi.nlm.nih.gov/pubmed/20000336
https://search.proquest.com/docview/734232715
https://pubmed.ncbi.nlm.nih.gov/PMC2805767
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9swDCb6OGyXbmu7LXsUQjfsZtSS7cg-FmmKXloUfQC7GXpQaIBFDubkkH9fSo6zptuwXW1ZsPVZ4EeR_AjwVRNjMyoziVW0m3JnbKJpfycpWWeXVQXmsVD44lZefS_PxkEm58tfIviCn-hJFe06bsOukMQQAv8Z3f4qfkxXUsvkGgvi47180NNHg-kx7abp-Y1PPk-LfGJnzl_91xu-hr0VjWSnHe5vYAv9PhycenKhp0v2jcXEznhivg8vRn1TtwPwl307XBY7z2PLGkejm3b2QBjZJbHOkMbV_EhGS5qZxRPDWF5CnJRNPCPCyMbeNjOi3dOJYTc4744QmfKWXYeril3ilLxwj4dwfz6-G10kq5YLicplOk9c0KMXWHBZulI6TZBVGl0RmKIreWrInJVYCIVauhIzS2zPkUtlsSTXKNXZW9jxjcf3IWdKIjc4NMrpHBVXQmprVRECr8O8MgM4Ikzq1ZZp6xgNF7xer-YAjnu46lknvfGnQawHsqalDNEO-rpm0dYyaBsKyYsBvOtwXc8SypPSLBsOQG4gvh4QNLc37_jJQ9TeFiUR3KH88K-X_wgvuzwDnvDqE-zMfy7wM2y3dnEUf99HJTPq-A
link.rule.ids 230,315,782,786,887,2769,27085,27933,27934,56747,56797
linkProvider American Chemical Society
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCbW7tBd9mj3SLe1wjD0ZszyS_axyFJkWFMUawfsZuhBoQEaOZiTQ_59KTlOm63AsKstCzIpgR9F8iPAZ0WITctUR0bSacqsNpGi8x3FZJ1tWuWYhULh8ZW4-FV-HW1ocnwtDC2ipZnaEMS_ZxfgX9S0CuYdd-BpXhAI9jBoeHVfAxmvGZfJQ04IlvcsQg8_9RZIt9sW6C9Y-Wd25ANzc_bifxb6Ep6vQSU77XbBK3iCbh8OTh051LMVO2EhzTPcn-_D3rBv8XYAbtI3x2WhDz22rLE0umnnN6QxsyIM6pO6mttouKKZWbg_DMUmhFDZ1DGCj2zkTDMnED6bavYDF92FIpPOsEv_VLIJzsgnd_gafp6NrofjaN2AIZKZiBeR9ez0CeZclLYUVpECK4U297jRljzWZNxKzBOJStgSU0PYz5KDZbAkRylW6RvYdY3Ddz6DSiDXWGhpVYaSy0QoY2Tuw7BFVukBHJEw6_UBausQG094vZHmAD71WqvnHRHHY4NYr8-aROljH_R3zbKthWc6TATPB_C2U-9mFl-sFKdpMQCxpfjNAM_Avf3GTW8CE3dSEtwtxOG_Fn8Me-PryXl9_u3i-3t41mUg8IhXH2B38XuJH2GnNcujsKPvAOxI82U
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RIgEXHi3Q5VEshLiFxnk5Oa62uyqCVhUFiVvkx1hdiXVWze5h_z1jJ1m6gIS4Jo7leDyabzwz3wC8U4TYtEx1ZCRpU2a1iRTpdxSTdbZplWMWCoXPrsTF9_J06mlyPgy1MLSIlmZqQxDfa_XS2J5hgJ-oeRVMPO7B3bwQlXe2xpOrX3WQcc-6TF5yQtB8YBK6_am3QrrdtUJ_QMvfMyRvmZzZo_9d7GN42INLNu5OwxO4g-4ADseOHOvFhr1nId0z3KMfwP3J0OrtENz50CSXhX702LLG0uimXV6T5MyGsKhP7mp-RJMNzczCPWIoOiGkyuaOEYxkU2eaJYHxxVyzL7jqLhaZdIZd-qeSneOCfHOHT-HbbPp1chb1jRgimYl4FVnPUp9gzkVpS2EVCbJSaHOPH23JY01GrsQ8kaiELTE1hAEtOVoGS3KYYpU-g33XODzymVQCucZCS6sylFwmQhkjcx-OLbJKj-CYNrTuFamtQ4w84fV2N0fwdpBcvewIOf42iA0yrWkrfQyE_q5Zt7XwjIeJ4PkInnci3s7ii5biNC1GIHaEvx3gmbh337j5dWDkTkqCvYV48a_Fv4F7l6ez-vPHi08v4UGXiMAjXr2C_dXNGl_DXmvWx-FQ_wTVBPXo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+species+of+phosphatidylinositol-cycle+intermediates+in+the+endoplasmic+reticulum+and+plasma+membrane&rft.jtitle=Biochemistry+%28Easton%29&rft.au=Shulga%2C+Yulia+V&rft.au=Myers%2C+David+S&rft.au=Ivanova%2C+Pavlina+T&rft.au=Milne%2C+Stephen+B&rft.date=2010-01-19&rft.eissn=1520-4995&rft.volume=49&rft.issue=2&rft.spage=312&rft.epage=317&rft_id=info:doi/10.1021%2Fbi901551e&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2960&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2960&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2960&client=summon